Skip to main content
. 2022 Aug 31;12(9):1212. doi: 10.3390/biom12091212

Figure 4.

Figure 4

(A) Preparation for immunostaining with anti-ACE2 antibody from skin samples of SARS-CoV-2-positive patients. Note the focal positivity of the immunolabeling of the basal keratinocytes and of some keratinocytes of the Malpighian (spinose) and granular layer (Immunohistochemistry anti-ACE2, original magnification: 4×). (B) Detail of image A showing mild positivity of the ACE2 immunolabeling of some adenomeres of eccrine sweat glands and fibroblasts (Immunohistochemistry anti-ACE2, original magnification: 20×).